ResearcherMount Sinai HospitalNo recent work listed
Eleftherios P. Diamandis
Matched on ORCID iD 0000-0002-1589-820X; OpenAlex author ID A5084226800. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2011: 2 papers · 2012: 1 paper · 2013: 4 papers · 2014: 1 paper · 2015: none · 2016: 1 paper
Papers 9
- Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker. Co-author DOI 10.1515/cclm-2015-0773↗
- Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0289↗
- Strategies for discovering novel pancreatic cancer biomarkers. First author DOI 10.1016/j.jprot.2012.09.025↗
- Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues. Last author DOI 10.1074/mcp.m112.023507↗
- Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. Last author DOI 10.1186/1471-2407-13-404↗
- Pancreatic cancer. First author DOI 10.1373/clinchem.2012.196642↗
- Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. Co-author DOI 10.1016/j.jss.2011.04.021↗
- Mining the malignant ascites proteome for pancreatic cancer biomarkers. Last author DOI 10.1002/pmic.201100264↗
- Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Last author DOI 10.1074/mcp.m111.008599↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alison Chan · 4 shared papers, 2013–2014 · strength 0.18
- Paper Strategies for discovering novel pancreatic cancer biomarkers. DOI 10.1016/j.jprot.2012.09.025↗
- Paper Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. DOI 10.1158/1078-0432.ccr-14-0289↗
- Paper Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. DOI 10.1186/1471-2407-13-404↗
- Ivan M. Blasutig · 4 shared papers, 2013–2014 · strength 0.18
- Paper Strategies for discovering novel pancreatic cancer biomarkers. DOI 10.1016/j.jprot.2012.09.025↗
- Paper Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. DOI 10.1158/1078-0432.ccr-14-0289↗
- Paper Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. DOI 10.1186/1471-2407-13-404↗
- Felix Rückert · 4 shared papers, 2011–2013 · strength 0.13
- Paper Pancreatic cancer. DOI 10.1373/clinchem.2012.196642↗
- Paper Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of panc… DOI 10.1074/mcp.m112.023507↗
- Paper Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. DOI 10.1016/j.jss.2011.04.021↗
- Mario Plebani · 1 shared paper, 2016 · strength 0.12
- Randall E. Brand · 3 shared papers, 2013–2014 · strength 0.12
- Paper Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. DOI 10.1158/1078-0432.ccr-14-0289↗
- Paper Pancreatic cancer. DOI 10.1373/clinchem.2012.196642↗
- Paper Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of panc… DOI 10.1074/mcp.m112.023507↗
- Shalini Makawita · 3 shared papers, 2011–2013 · strength 0.10
- Paper Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. DOI 10.1186/1471-2407-13-404↗
- Paper Mining the malignant ascites proteome for pancreatic cancer biomarkers. DOI 10.1002/pmic.201100264↗
- Paper Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic… DOI 10.1074/mcp.m111.008599↗
- Christian P. Pilarsky · 3 shared papers, 2011–2013 · strength 0.09
- Paper Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of panc… DOI 10.1074/mcp.m112.023507↗
- Paper Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method. DOI 10.1016/j.jss.2011.04.021↗
- Paper Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic… DOI 10.1074/mcp.m111.008599↗
- Randy S. Haun · 2 shared papers, 2013 · strength 0.08
- Caitlin C Chrystoja · 2 shared papers, 2013 · strength 0.07
- Hari Kosanam · 2 shared papers, 2011–2013 · strength 0.07
- Steve Gallinger · 2 shared papers, 2011–2013 · strength 0.06
- Paper Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. DOI 10.1186/1471-2407-13-404↗
- Paper Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic… DOI 10.1074/mcp.m111.008599↗
- Robert Grützmann · 2 shared papers, 2011–2012 · strength 0.06
- Stefano Serra · 1 shared paper, 2014 · strength 0.05
- Rafael Molina · 1 shared paper, 2013 · strength 0.04
- Christian Krautz · 1 shared paper, 2012 · strength 0.03
- Kristin Werner · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.